Ch nh: Dng cho mi la tui, tng cng sc khe v lm trng da t nhin
Despite all these advancements and promising new treatments, the WHO report states,"Overall, the clinical pipeline and recently approved antibiotics are insufficient to tackle the challenge of increasing emergence and spread of antimicrobial resistance. Thus, persistent research is necessary to enhance available therapeutic options against the rising MDR infection risk
FDA and the PCAC do review clinical input from practitioners, and well-documented comments describing clinical outcomes, patient need, or safety observations can meaningfully inform the Committees recommendations
Understanding what that research shows and equally important, what it does not yet show is one of the most useful things you can do before evaluating any BPC-157 product
Bulletin of Experimental Biology and Medicine, 160(4), 494497